PSMA-guided Salvage Radiation for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 19 Nov 2025: Trial registered, NCT07234981
  2. 31 Mar 2026: Trial started, NCT07234981

The trials

NCT07234981: PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer

State
Under way
Phase
Phase 2
People
54 planned
Started
31 Mar 2026
Primary completion
5 Sep 2029
Arms
De-escalated PSMA-guided salvage radiation
Results
None posted
  1. 19 Nov 2025: Trial registered
  2. 31 Mar 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.